Abstract A unique pentasaccharide sequence of heparin has been proposed as the minimum structural requirement for binding to antithrombin and accelerating the inhibitory effect of this protein on a number of procoagulant proteases. This has been confirmed by the total chemical synthesis of the corresponding pentasaccharide, which indeed displayed a high affinity for antithrombin, resulting in a notably selective anti-Xa activity.
INTRODUCTION
Heparin, a sulfated polysaccharide belonging to the class of glycosaminoglycans, widely distributed in animal tissue, is currently used in therapy as an anticoagulant and antithrombotic agent. Heparin acts mainly by binding to antithrombin (AT) and accelerating the inhibitory effect of this protein on a number of procoagulant proteases. In order to determine the heparin sequence responsible for the specific binding to AT, the structure of various heparin fragments prepared by affinity chromatography and possessing high affinity for AT has been determined. This structural work led to the hypothesis that the minimun sequence in heparin that binds to AT was contained in the following pentasaccharide DEFGH. The next scheme delineates the strategy which was used by us in order to synthesize the trisaccharide DEF (ref. , sym-coll., CH2CI2.
90Y.
Alcaline deacetylation followed by esterification gave a polyol which was successfully sulfated and deprotected to give the traget molecule (ref. 6). Much to our pleasure, this compound displayed a high affinity for AT, resulting in a notably selective anti-Xa activity. 
